A phase II study of ramucirumab (IMC-1121B) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma.
about
Evolution of ramucirumab in the treatment of cancer - A review of literatureAntivascular therapy for epithelial ovarian cancer.Ramucirumab (Cyramza): A Breakthrough Treatment for Gastric Cancer.The effect of celecoxib on tumor growth in ovarian cancer cells and a genetically engineered mouse model of serous ovarian cancer.Incidence and relative risk of hemorrhagic events associated with ramucirumab in cancer patients: a systematic review and meta-analysis.Impact of VEGF gene polymorphisms in elderly cancer patients: clinical outcome and toxicity.Targeted agents and combinations in ovarian cancer: where are we now?Risk of gastrointestinal perforation in cancer patients receiving ramucirumab: a meta-analysis of randomized controlled trials.A critical review on ramucirumab in the treatment of advanced urothelial cancer.Strategies for clinical development of monoclonal antibodies beyond first-in-human trials: tested doses and rationale for dose selection.A phase 1 study of ramucirumab in Japanese patients with advanced solid tumors.
P2860
Q28276412-EC880F05-8AB7-4D73-90DD-9340F58D6695Q33583598-E97A86E4-66BE-4321-9AE3-0AE302991C33Q35831418-4ABF2201-7A53-4982-8115-143A9D96ADC8Q37457596-1A59687E-88B7-45AC-8C9D-665BBFAF5A48Q37662388-D1578008-6DDC-4091-A8C7-7D3602B306C7Q38307997-7929A70F-116C-4B98-85A4-627E8EEEFD3DQ38760610-63FAD571-56AE-45AA-BF53-45D769E5DB30Q41650735-4F4F3ACB-60F8-424B-B3FA-45113D0D5B70Q47787312-4BE1357C-5E5A-4142-B8D1-739D4A7208E7Q50041876-FE395ACD-ED9A-4DBD-A3DE-A3EFDC69E751Q51154279-B39A9AC2-DEDE-4D5A-A24F-9F1AAA4CCCF1
P2860
A phase II study of ramucirumab (IMC-1121B) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 July 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A phase II study of ramuciruma ...... primary peritoneal carcinoma.
@en
A phase II study of ramuciruma ...... primary peritoneal carcinoma.
@nl
type
label
A phase II study of ramuciruma ...... primary peritoneal carcinoma.
@en
A phase II study of ramuciruma ...... primary peritoneal carcinoma.
@nl
prefLabel
A phase II study of ramuciruma ...... primary peritoneal carcinoma.
@en
A phase II study of ramuciruma ...... primary peritoneal carcinoma.
@nl
P2093
P2860
P1433
P1476
A phase II study of ramuciruma ...... r primary peritoneal carcinoma
@en
P2093
Adarsh Joshi
Gini F Fleming
Hoa Nguyen
Jonathan D Schwartz
Kathleen M Moore
Martin Gore
Patricia Braly
Rebecca R Hozak
Richard T Penson
Susana Banerjee
P2860
P304
P356
10.1016/J.YGYNO.2014.06.029
P407
P577
2014-07-10T00:00:00Z